Industry
Biotechnology
Topic
Product Launch
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Product Launch in Biotechnology
... Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that the U.S. Food and Drug Administration (FDA) ...
... BRISBANE, Calif., April 16, 2018 (GLOBE NEWSWIRE) -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company pursuing cutting-edge science to develop its proprietary ...
... the organization for 45 years, the company said. — PRIYANKA DAYAL MCCLUSKEY Amgen to build $160m plant in Rhode Island Drug giant Amgen Inc. plans ...
... research to the investment community. Today we are offering reports on BRKR, CRL, DXCM, and EXAS which can be accessed for free by signing up ...
... Wednesday. Only ride-sharing company Uber, restaurant delivery service DoorDash and drug developer Moderna Therapeutics had larger investments in the quarter. Magic Leap's latest financing, $461 ...
... Allergan Plc (Ireland)ARK Skincare (UK)Avon Products Inc. (UK)Bayer AG (Germany)Beiersdorf AG (Germany)Biomod Concepts, Inc. (Canada)Chanel SA (France)Christian Dior SA (France)Clarins (France)Ella Bache (France)Estee Lauder Inc. ...
... from the third party manufacturer of PREXXARTAN (valsartan) oral solution against Carmel Biosciences, Inc. March 28: Medicure Announces Further Up-Date on PREXXARTAN To view Recent ...
... from the third party manufacturer of PREXXARTAN (valsartan) oral solution against Carmel Biosciences, Inc. ("Carmel"). The claim disputes the rights granted by Carmel to the ...
... Market SALT LAKE CITY, UT, March 28, 2018 (GLOBE NEWSWIRE) -- EnviroTechnologies International, Inc., a publicly traded company (OTC Pink: ETII) that develops and markets ...
... Pink:POTN) On Friday, March 23rd, PotNetwork Holding Inc.'s wholly owned subsidiary, Diamond CBD Inc., closed out a highly advantageous week at the Global Pet Expo, ...
... - HCC) - 1st line Clinical trial being conducted by Transgene's partner, SillaJen (sponsor) Ongoing recruitment. First patient treated in Europe in April 2017 Trial ...
... Study II. EXECUTIVE SUMMARY 1. OUTLOOK Bioseparation Systems - Invaluable Tools in Biopharmaceutical Manufacturing US Remains Market Leader; Developing Countries to Drive Market Growth Chromatography ...
... aware of between the owner of the New Drug Application ("NDA"), Carmel Biosciences, Inc. ("Carmel") and the third party manufacturer of the product. Medicure had ...
... BRISBANE - Humanigen, Inc. (OTCQB: HGEN), a biopharmaceutical company pursuing cutting-edge science to develop its ...
... BRISBANE, Calif., March 15, 2018 (GLOBE NEWSWIRE) -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company pursuing cutting-edge science to develop its proprietary ...
... SOUTH SAN FRANCISCO - Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported financial results for the fourth quarter and year ...
... Holding, Inc. (OTC Pink:POTN) ("Company"), announced today that its wholly owned subsidiary, Diamond CBD, Inc., is currently exhibiting at the 55th ASD Market Week trade ...
... Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today reported financial results for the fourth quarter and year ...
... this morning are the following stocks: Mallinckrodt PLC (NYSE: MNK), Momenta Pharmaceuticals Inc. (NASDAQ: MNTA), Mylan N.V. (NASDAQ: MYL), and Neurocrine Biosciences Inc. (NASDAQ: NBIX). ...
... Prevent Critical CAR-T-related Neurotoxicity BRISBANE, Calif., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company pursuing cutting-edge science to develop its proprietary ...
... and niche players such as: - AMUL - Attune Foods, LLC - Bifodan A/S - Biocare Copenhagen ApS - BioGaia AB - Bright Food (Group) ...
... Alcami Corporation, a leading provider of custom end-to-end development and manufacturing services for ...
... US in June 2015-- CAMBRIDGE, Mass., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) today announced that the U.S. Food and Drug Administration ...
... Optima Curis Inc., a Los Angeles based healthcare solutions company, announced the first glimpse ...
... drop below $100. In fact, some big Silicon Valley start-ups, led by 23andMe, have capitalized on this rapid advance and already offer personal DNA testing ...
Subscribe now for full coverage on Product Launch in Biotechnology
Start My Free Trial